 | • レポートコード：MRC2304A002 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、254ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の当調査レポートでは、2021年に4,914.42百万ドルであった世界のアレルギー診断市場規模が2022年に5,411.79百万ドルへと拡大、更に2027年までにCAGR 10.29％で成長して8,848.44百万ドルに達すると予測しています。当書は、アレルギー診断の世界市場を総合的に分析し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、種類別分析（薬物アレルゲン、食物アレルゲン、吸入アレルゲン）、製品タイプ別分析（アッセイキット、消耗品、器具）、検査別分析（インビトロ検査、インビボ検査）、エンドユーザー別分析（学術・研究機関、診断研究所、病院検査室）、地域別分析（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）、競争状況、企業情報などの構成でまとめています。なお、当書には、Alcon Laboratories, Inc.、ALK、Allergy Therapeutics PLC、Astra Biotech GmbH、Biomérieux SA、Danaher Corporation、Dr. Fooke Laboratorien GmbH、EUROIMMUN AG、GA Generic Assays GmbH、HAL Allergy B.V.、Hitachi Chemical Co.,Ltd.、Hob Biotech Group Suzhou Co.,Ltd.などの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界のアレルギー診断市場規模：種類別 - 薬物アレルゲンの市場規模 - 食物アレルゲンの市場規模 - 吸入アレルゲンの市場規模 ・世界のアレルギー診断市場規模：製品タイプ別 - アレルギー診断用アッセイキットの市場規模 - アレルギー診断用消耗品の市場規模 - アレルギー診断用器具の市場規模 ・世界のアレルギー診断市場規模：検査別 - インビトロ検査の市場規模 - インビボ検査の市場規模 ・世界のアレルギー診断市場規模：エンドユーザー別 - 学術・研究機関における市場規模 - 診断研究所における市場規模 - 病院検査室における市場規模 ・世界のアレルギー診断市場規模：地域別 - 南北アメリカのアレルギー診断市場規模 アメリカのアレルギー診断市場規模 カナダのアレルギー診断市場規模 ブラジルのアレルギー診断市場規模 ... - アジア太平洋のアレルギー診断市場規模 日本のアレルギー診断市場規模 中国のアレルギー診断市場規模 インドのアレルギー診断市場規模 韓国のアレルギー診断市場規模 台湾のアレルギー診断市場規模 ... - ヨーロッパ/中東/アフリカのアレルギー診断市場規模 イギリスのアレルギー診断市場規模 ドイツのアレルギー診断市場規模 フランスのアレルギー診断市場規模 ロシアのアレルギー診断市場規模 ... - その他地域のアレルギー診断市場規模 ・競争状況 ・企業情報 |
The Global Allergy Diagnostics Market size was estimated at USD 4,914.42 million in 2021 and expected to reach USD 5,411.79 million in 2022, and is projected to grow at a CAGR 10.29% to reach USD 8,848.44 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Allergy Diagnostics to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Type, the market was studied across Drug Allergen, Food Allergen, and Inhaled Allergen.
Based on Product Type, the market was studied across Assay Kits, Consumables, and Instruments. The Instruments is further studied across Immunoassay Analyzers and Luminometers.
Based on Test, the market was studied across In-Vitro Tests and In-Vivo Tests.
Based on End User, the market was studied across Academic Research Institutes, Diagnostic Laboratories, and Hospital-Based Laboratories.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Allergy Diagnostics market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Allergy Diagnostics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Allergy Diagnostics Market, including Alcon Laboratories, Inc., ALK, Allergy Therapeutics PLC, Astra Biotech GmbH, Biomérieux SA, Danaher Corporation, Dr. Fooke Laboratorien GmbH, EUROIMMUN AG, GA Generic Assays GmbH, HAL Allergy B.V., Hitachi Chemical Co.,Ltd., Hob Biotech Group Suzhou Co.,Ltd., Hycor Biomedical, INDOOR Biotechnologies, Inc., Lincoln Diagnostics,Inc., Omega Diagnostics Group PLC, Parkway Pantai, R-Biopharm AG, ROXALL Medizin GmbH, Siemens AG, Stallergenes Greer PLC, Tecan Trading AG, Switzerland, Theradiag, Demeditec Diagnostics GmbH, and Thermo Fisher Scientific Inc..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Allergy Diagnostics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Allergy Diagnostics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Allergy Diagnostics Market?
4. What is the competitive strategic window for opportunities in the Global Allergy Diagnostics Market?
5. What are the technology trends and regulatory frameworks in the Global Allergy Diagnostics Market?
6. What is the market share of the leading vendors in the Global Allergy Diagnostics Market?
7. What modes and strategic moves are considered suitable for entering the Global Allergy Diagnostics Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidences of allergic diseases coupled with environmental pollution levels
5.1.1.2. Favourable reimbursement and insurance poilicies
5.1.2. Restraints
5.1.2.1. Limited awareness about the allergic testing
5.1.3. Opportunities
5.1.3.1. Advencement in allergic diagnosis products with enhanced sensitivity specificity and faster diagnosis
5.1.3.2. Potential in untapped economies of APAC
5.1.4. Challenges
5.1.4.1. Affordability of allergy diagnostics kits and instruments among small laboratories and physician clinics
5.2. Cumulative Impact of COVID-19
6. Allergy Diagnostics Market, by Type
6.1. Introduction
6.2. Drug Allergen
6.3. Food Allergen
6.4. Inhaled Allergen
7. Allergy Diagnostics Market, by Product Type
7.1. Introduction
7.2. Assay Kits
7.3. Consumables
7.4. Instruments
7.5.1. Immunoassay Analyzers
7.5.2. Luminometers
8. Allergy Diagnostics Market, by Test
8.1. Introduction
8.2. In-Vitro Tests
8.3. In-Vivo Tests
9. Allergy Diagnostics Market, by End User
9.1. Introduction
9.2. Academic Research Institutes
9.3. Diagnostic Laboratories
9.4. Hospital-Based Laboratories
10. Americas Allergy Diagnostics Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Allergy Diagnostics Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Allergy Diagnostics Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Alcon Laboratories, Inc.
14.1.1. Business Overview
14.1.2. Key Executives
14.1.3. Product & Services
14.2. ALK
14.2.1. Business Overview
14.2.2. Key Executives
14.2.3. Product & Services
14.3. Allergy Therapeutics PLC
14.3.1. Business Overview
14.3.2. Key Executives
14.3.3. Product & Services
14.4. Astra Biotech GmbH
14.4.1. Business Overview
14.4.2. Key Executives
14.4.3. Product & Services
14.5. Biomérieux SA
14.5.1. Business Overview
14.5.2. Key Executives
14.5.3. Product & Services
14.6. Danaher Corporation
14.6.1. Business Overview
14.6.2. Key Executives
14.6.3. Product & Services
14.7. Dr. Fooke Laboratorien GmbH
14.7.1. Business Overview
14.7.2. Key Executives
14.7.3. Product & Services
14.8. EUROIMMUN AG
14.8.1. Business Overview
14.8.2. Key Executives
14.8.3. Product & Services
14.9. GA Generic Assays GmbH
14.9.1. Business Overview
14.9.2. Key Executives
14.9.3. Product & Services
14.10. HAL Allergy B.V.
14.10.1. Business Overview
14.10.2. Key Executives
14.10.3. Product & Services
14.11. Hitachi Chemical Co.,Ltd.
14.11.1. Business Overview
14.11.2. Key Executives
14.11.3. Product & Services
14.12. Hob Biotech Group Suzhou Co.,Ltd.
14.12.1. Business Overview
14.12.2. Key Executives
14.12.3. Product & Services
14.13. Hycor Biomedical
14.13.1. Business Overview
14.13.2. Key Executives
14.13.3. Product & Services
14.14. INDOOR Biotechnologies, Inc.
14.14.1. Business Overview
14.14.2. Key Executives
14.14.3. Product & Services
14.15. Lincoln Diagnostics,Inc.
14.15.1. Business Overview
14.15.2. Key Executives
14.15.3. Product & Services
14.16. Omega Diagnostics Group PLC
14.16.1. Business Overview
14.16.2. Key Executives
14.16.3. Product & Services
14.17. Parkway Pantai
14.17.1. Business Overview
14.17.2. Key Executives
14.17.3. Product & Services
14.18. R-Biopharm AG
14.18.1. Business Overview
14.18.2. Key Executives
14.18.3. Product & Services
14.19. ROXALL Medizin GmbH
14.19.1. Business Overview
14.19.2. Key Executives
14.19.3. Product & Services
14.20. Siemens AG
14.20.1. Business Overview
14.20.2. Key Executives
14.20.3. Product & Services
14.21. Stallergenes Greer PLC
14.21.1. Business Overview
14.21.2. Key Executives
14.21.3. Product & Services
14.22. Tecan Trading AG, Switzerland
14.22.1. Business Overview
14.22.2. Key Executives
14.22.3. Product & Services
14.23. Theradiag, Demeditec Diagnostics GmbH
14.23.1. Business Overview
14.23.2. Key Executives
14.23.3. Product & Services
14.24. Thermo Fisher Scientific Inc.
14.24.1. Business Overview
14.24.2. Key Executives
14.24.3. Product & Services
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing